RJA
ZLAB icon

Raymond James & Associates’s Zai Lab ZLAB Stock Holding History

Raymond James & Associates’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,674
Closed -$374K – 4055
2023
Q4 		$374K Sell
13,674
-5,200
-28% -$137K ﹤0.01% 3140
2023
Q3 		$459K Sell
18,874
-500
-3% -$13.3K ﹤0.01% 2952
2023
Q2 		$537K Buy
+19,374
New +$634K ﹤0.01% 2895
2021
Q4 		– Sell
-2,346
Closed -$247K – 4292
2021
Q3 		$247K Sell
2,346
-674
-22% -$96.8K ﹤0.01% 3551
2021
Q2 		$535K Buy
3,020
+1,038
+52% +$167K ﹤0.01% 3033
2021
Q1 		$264K Buy
+1,982
New +$307K ﹤0.01% 3447

Other funds holding ZLAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Raymond James & Associates's ZLAB Position: Q1 2024 in Review

Raymond James & Associates sold out of Zai Lab (ZLAB) in Q1 2024, closing a stake of 13,674 shares — an estimated $374K sold.

Raymond James & Associates first reported a position in ZLAB in Q1 2021 and held it in 6 quarters. The position peaked at $537K in Q2 2023. 116 funds tracked by Wall St. Rank hold ZLAB as of Q1 2024.

  • Raymond James & Associates reported no remaining Zai Lab position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 13,674 Zai Lab shares in Q1 2024, an estimated $374K.
  • Raymond James & Associates first reported a position in Zai Lab in Q1 2021 and held it in 6 quarters.
  • Raymond James & Associates's Zai Lab position peaked at $537K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Zai Lab as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.